Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial
生物类似药SB15与参考药物阿柏西普治疗新生血管性年龄相关性黄斑变性:一项3期临床试验的1年及转换治疗结果
期刊:BMJ Open Ophthalmology
影响因子:2.2
doi:10.1136/bmjophth-2023-001561
Sadda, SriniVas R; Bradvica, Mario; Vajas, Attila; Sagong, Min; Ernest, Jan; Studnička, Jan; Veith, Miroslav; Wylegala, Edward; Patel, Sunil; Yun, Cheolmin; Orski, Michal; Astakhov, Sergei; Tóth-Molnár, Edit; Csutak, Adrienne; Enyedi, Lajos; Choi, Wooree; Oh, Inkyung; Jang, Hyerin; Woo, Se Joon